Indication.Bio

Indication BioScience LLC is an early-stage drug development company focused on the identification, establishment of intellectual properties, and funding of early stage research for new compounds and formulations. We have developed and been granted patents for a novel approach for the treatment of hypercholesterolemia by reformulating certain existing statin drugs. Indication BioScience LLC first intends to fund supportive research for these hypercholesterolemia drugs, then will seek licensing opportunities. In addition to our hypercholesterolemia drug platform, “Statin+,” we will also establish a drug discovery platform to further the discovery new molecular entities. The new molecules will target receptors that have been shown as potential targets for treating pain, cancer, neurodegenerative conditions, metabolic disorders, bone growth, cardiovascular and immune system function.